Suppr超能文献

实时荧光共振能转移监测假尿嘧啶核苷合成的早期中间体停滞的形成。

Formation of a stalled early intermediate of pseudouridine synthesis monitored by real-time FRET.

机构信息

Institute of Pharmacy and Molecular Biotechnology, Department of Chemistry, Heidelberg University, 69120 Heidelberg, Germany.

出版信息

RNA. 2010 Mar;16(3):610-20. doi: 10.1261/rna.1832510. Epub 2010 Jan 27.

Abstract

Pseudouridine is the most abundant of more than 100 chemically distinct natural ribonucleotide modifications. Its synthesis consists of an isomerization reaction of a uridine residue in the RNA chain and is catalyzed by pseudouridine synthases. The unusual reaction mechanism has become the object of renewed research effort, frequently involving replacement of the substrate uridines with 5-fluorouracil (f(5)U). f(5)U is known to be a potent inhibitor of pseudouridine synthase activity, but the effect varies among the target pseudouridine synthases. Derivatives of f(5)U have previously been detected, which are thought to be either hydrolysis products of covalent enzyme-RNA adducts, or isomerization intermediates. Here we describe the interaction of pseudouridine synthase 1 (Pus1p) with f(5)U-containing tRNA. The interaction described is specific to Pus1p and position 27 in the tRNA anticodon stem, but the enzyme neither forms a covalent adduct nor stalls at a previously identified reaction intermediate of f(5)U. The f(5)U27 residue, as analyzed by a DNAzyme-based assay using TLC and mass spectrometry, displayed physicochemical properties unaltered by the reversible interaction with Pus1p. Thus, Pus1p binds an f(5)U-containing substrate, but, in contrast to other pseudouridine synthases, leaves the chemical structure of f(5)U unchanged. The specific, but nonproductive, interaction demonstrated here thus constitutes an intermediate of Pus turnover, stalled by the presence of f(5)U in an early state of catalysis. Observation of the interaction of Pus1p with fluorescence-labeled tRNA by a real-time readout of fluorescence anisotropy and FRET revealed significant structural distortion of f(5)U-tRNA structure in the stalled intermediate state of pseudouridine catalysis.

摘要

假尿嘧啶核苷是 100 多种化学性质不同的天然核苷酸修饰物中含量最丰富的一种。它的合成由 RNA 链中尿嘧啶残基的异构化反应组成,由假尿嘧啶核苷合成酶催化。这种不寻常的反应机制已成为新的研究目标,通常涉及用 5-氟尿嘧啶(f(5)U)替代底物尿嘧啶。f(5)U 已知是假尿嘧啶核苷合成酶活性的有效抑制剂,但对靶假尿嘧啶核苷合成酶的影响各不相同。f(5)U 的衍生物以前已经被检测到,它们被认为是共价酶-RNA 加合物的水解产物,或者是异构化中间体。在这里,我们描述了假尿嘧啶核苷合成酶 1(Pus1p)与含有 f(5)U 的 tRNA 的相互作用。所描述的相互作用是特异性的,涉及 Pus1p 和 tRNA 反密码子茎中的 27 位,但该酶既不形成共价加合物,也不在之前鉴定的 f(5)U 反应中间体处停滞。通过使用 TLC 和质谱的基于 DNA 酶的测定法分析的 f(5)U27 残基,显示其理化性质在与 Pus1p 的可逆相互作用中未改变。因此,Pus1p 结合含有 f(5)U 的底物,但与其他假尿嘧啶核苷合成酶不同,它使 f(5)U 的化学结构保持不变。这里展示的特异性但非生产性相互作用因此构成了 Pus 周转的中间产物,被催化早期存在的 f(5)U 所阻止。通过实时读取荧光各向异性和 FRET 观察 Pus1p 与荧光标记 tRNA 的相互作用,揭示了在假尿嘧啶催化的停滞中间状态下 f(5)U-tRNA 结构的显著结构扭曲。

相似文献

1
Formation of a stalled early intermediate of pseudouridine synthesis monitored by real-time FRET.
RNA. 2010 Mar;16(3):610-20. doi: 10.1261/rna.1832510. Epub 2010 Jan 27.
2
The yeast tRNA:pseudouridine synthase Pus1p displays a multisite substrate specificity.
RNA. 1998 Jul;4(7):856-69. doi: 10.1017/s1355838298980396.
6
The pseudouridine synthases: revisiting a mechanism that seemed settled.
J Am Chem Soc. 2004 Oct 13;126(40):12758-9. doi: 10.1021/ja046375s.
7
Pus1p-dependent tRNA pseudouridinylation becomes essential when tRNA biogenesis is compromised in yeast.
J Biol Chem. 2001 Dec 7;276(49):46333-9. doi: 10.1074/jbc.M107141200. Epub 2001 Sep 24.
8
Pseudouridine synthase 3 from mouse modifies the anticodon loop of tRNA.
Biochemistry. 2000 Oct 17;39(41):12723-30. doi: 10.1021/bi001109m.
9
A previously unidentified activity of yeast and mouse RNA:pseudouridine synthases 1 (Pus1p) on tRNAs.
RNA. 2006 Aug;12(8):1583-93. doi: 10.1261/rna.100806. Epub 2006 Jun 27.
10
Pseudouridine synthases.
Chem Biol. 2006 Nov;13(11):1125-35. doi: 10.1016/j.chembiol.2006.09.009.

引用本文的文献

1
RNA modification: mechanisms and therapeutic targets.
Mol Biomed. 2023 Aug 24;4(1):25. doi: 10.1186/s43556-023-00139-x.
2
Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method.
J Pharm Anal. 2021 Feb;11(1):77-87. doi: 10.1016/j.jpha.2020.04.001. Epub 2020 Apr 7.
3
Dye label interference with RNA modification reveals 5-fluorouridine as non-covalent inhibitor.
Nucleic Acids Res. 2014 Nov 10;42(20):12735-45. doi: 10.1093/nar/gku908. Epub 2014 Oct 9.
5
Reliable semi-synthesis of hydrolysis-resistant 3'-peptidyl-tRNA conjugates containing genuine tRNA modifications.
Nucleic Acids Res. 2010 Oct;38(19):6796-802. doi: 10.1093/nar/gkq508. Epub 2010 Jun 4.

本文引用的文献

1
Structural mechanism of substrate RNA recruitment in H/ACA RNA-guided pseudouridine synthase.
Mol Cell. 2009 May 14;34(4):427-39. doi: 10.1016/j.molcel.2009.05.005.
2
Structure of a functional ribonucleoprotein pseudouridine synthase bound to a substrate RNA.
Nat Struct Mol Biol. 2009 Jul;16(7):740-6. doi: 10.1038/nsmb.1624. Epub 2009 May 28.
3
Archaeal Pus10 proteins can produce both pseudouridine 54 and 55 in tRNA.
RNA. 2008 Dec;14(12):2521-7. doi: 10.1261/rna.1276508. Epub 2008 Oct 24.
4
RNA intramolecular dynamics by single-molecule FRET.
Curr Protoc Nucleic Acid Chem. 2008 Sep;Chapter 11:Unit 11.12. doi: 10.1002/0471142700.nc1112s34.
6
RNA-based 5-fluorouracil toxicity requires the pseudouridylation activity of Cbf5p.
Genetics. 2008 May;179(1):323-30. doi: 10.1534/genetics.107.082727.
7
Evidence that tRNA modifying enzymes are important in vivo targets for 5-fluorouracil in yeast.
RNA. 2008 Apr;14(4):666-74. doi: 10.1261/rna.966208. Epub 2008 Feb 26.
8
Use of DNAzymes for site-specific analysis of ribonucleotide modifications.
RNA. 2008 Jan;14(1):180-7. doi: 10.1261/rna.742708. Epub 2007 Nov 12.
9
A methyl group controls conformational equilibrium in human mitochondrial tRNA(Lys).
J Am Chem Soc. 2007 Nov 7;129(44):13382-3. doi: 10.1021/ja075520+. Epub 2007 Oct 17.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验